Serena Granziera
Overview
Explore the profile of Serena Granziera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denas G, Zoppellaro G, Granziera S, Pagliani L, Noventa F, Iliceto S, et al.
JACC Adv
. 2024 Jun;
2(7):100569.
PMID: 38939480
Background: Age and frailty are associated with underuse of anticoagulation in elderly patients with atrial fibrillation (AF). Objectives: This study aimed at assessing major clinical outcomes in very elderly patients...
2.
Pleming W, Barco S, Voci D, Sacco C, Zane F, Granziera S, et al.
Hamostaseologie
. 2022 Mar;
42(4):261-267.
PMID: 35255510
Background: Lemierre syndrome is a potentially life-threatening disease, which affects otherwise healthy young adults and adolescents. It is characterized by acute neck vein thrombosis and septic embolism, usually complicating a...
3.
Valerio L, Corsi G, Granziera S, Holm K, Hotz M, Jankowski M, et al.
Thromb Res
. 2021 Mar;
202:36-39.
PMID: 33713865
No abstract available.
4.
Granziera S, Alessandri A, Lazzaro A, Zara D, Scarpa A
Aging Clin Exp Res
. 2020 Jun;
33(4):965-971.
PMID: 32529596
Introduction: Non-pharmacological interventions are increasingly being acknowledged as valuable options to overcome or reduce functional problems in patients with Parkinson's disease. In the last decades, Nordic Walking was employed and...
5.
Barco S, Granziera S, Coppens M, Douxfils J, Nijkeuter M, Riva N, et al.
Thromb Haemost
. 2019 Feb;
119(4):675-684.
PMID: 30731492
Background: Time in therapeutic range (TTR) measures the quality of vitamin K antagonist (VKA) anticoagulation. In patients with atrial fibrillation, the dichotomized SAMe-TT2-R2 score (≥2 vs. < 2 points) can...
6.
Zoppellaro G, Veronese N, Granziera S, Gobbi L, Stubbs B, Cohen A
Semin Hematol
. 2018 Dec;
55(4):182-184.
PMID: 30502844
Background: Multiple myeloma (MM) is a common hematological disorder, often complicated by venous thromboembolism, especially during treatment with immunomodulatory drugs. Acetylsalicylic acid (ASA) has been extensively used as thromboprophylaxis but...
7.
Sacco C, Zane F, Granziera S, Holm K, Creemers-Schild D, Hotz M, et al.
Hamostaseologie
. 2018 Aug;
39(1):76-86.
PMID: 30071559
Lemierre syndrome usually affects otherwise healthy adolescents or young adults and occurs at an overall rate of 1 to 10 cases per million person-years with an estimated fatality rate of...
8.
Zoppellaro G, Granziera S, Bertozzo G, Denas G, Marigo L, Petruzzellis F, et al.
Thromb Haemost
. 2017 Jul;
117(9):1828-1830.
PMID: 28726972
No abstract available.
9.
Cohen A, Granziera S, Veronese N, Zoppellaro G
Semin Respir Crit Care Med
. 2017 Feb;
38(1):29-39.
PMID: 28208196
The direct oral anticoagulants (DOACs) have been compared with parenteral anticoagulants and vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE) in several robust studies. DOACs have shown...
10.
Groppa F, Coin A, De Rosa G, Granziera S, Alexopoulos C, Pamio M, et al.
Ther Drug Monit
. 2015 Sep;
38(1):108-13.
PMID: 26349080
Background: In humans, donepezil (D) is metabolized to 5-O-desmethyl-donepezil (5DD), 6-O-desmethyl-donepezil (6DD), and donepezil-N-oxide (DNox). Although 6DD and DNox are pharmacologically active, the activity of 5DD is unknown. At present,...